retatrutide nejm Peptide: The Breakthrough Triple-Hormone Research Changing Obesity Science This week's most cited articles:

Why the GutMetabolism Connection Matters

One of the telehealth platforms Lilly is now suing, Mochi Health, planned to continue selling compounded versions of tirzepatide, betting that offering personalized treatments would keep it out of legal trouble, Mochi CEO Myra Ahmad told CNBC in March

According to the report, the FDA chose not to enforce this provision because it has never finalized a standard memorandum of understanding

Comparative profiling against single and dual incretin receptor compounds in preclinical models

This shift from weekly injections to daily pills is expected to dramatically expand the patient population using GLP-1 therapy